Citations

Clear

3485 citation(s) found for "Sy, Sarah".

1331: INTERRUPTIONS AND PATIENT SAFETY: A STUDY OF NURSE-TO-NURSE HANDOFFS IN CRITICAL CARE
Rhudy, Lori M. , Johnson, Maren, Keigley, Danielle S., Kraft, Sarah , Krecke, Catherine, Maxson, Pamela M., McGill, Sharon M., Warfield, Karen T.

Mayo Clinic

Critical Care Medicine | December 18, 2018 | Volume: 47 | Issue: 1 | Pages: 642-642

10.1097/01.ccm.0000552075.11601.f5 Get It

Integrative data fusion for comprehensive assessment of a novel CHEK2 variant using combined genomics, imaging, and functional–structural assessments via protein
Hines, Stephanie L., Jackson, Jessica L. , Macklin, Sarah , Caulfield, Thomas R. , Caulfield, Thomas R , Mohammad, Ahmed N.

Mayo Clinic

Molecular Omics | December 18, 2018 | Volume: 15 | Issue: 1 | Pages: 59-66

10.1039/c8mo00137e | PMID 30633282 Get It

Abstract The CHEK2 gene and its encoded protein Chk2 have a well-known role in cancers, especially those related to breast cancer mediated through the BRCA1 gene. Additionally Chk2 has a crucial role in DNA repair, apoptosis and the cell cycle, which is why classification of variants of uncertain significance (VUS) is an area highly sought for a better elucidation of the “genomic effect” that results. Because it can often take years before enough clinical data is accumulated, and the costly and expensive functional analysis for individual variants presents a significant hurdle, it is important to identify other tools to help aid in clarifying the impact of specific variants on a protein's function and eventually the patient's health outcome. Here we describe a newly identified CHEK2 variant and analyze with an integrated approach combining genomics (whole exome analysis), clinical study, radiographic imaging, and protein informatics to identify and predict the functional impact of the VUS on the protein's behavior and predicted impact on the related pathways. The observed and analyzed defects in the protein were consistent with the expected clinical effect. Here, we support the use of personalized protein modeling and informatics and further our goal of developing a large-scale protein deposition archive for all protein-level VUS.
Blood pressure reactivity at onset of mental stress determines sympathetic vascular response in young adults
Sayed, Khadigeh El, Macefield, Vaughan G. , Taylor, Chloe E. , Hissen, Sarah L. , Joyner, Michael J. , Macefield, Vaughan G

Mayo Clinic

Physiological Reports | December 15, 2018 | Volume: 6 | Issue: 24 | Pages: No page available

10.14814/phy2.13944 | PMID 30552755 Get It

Practical Implementation of a Single-Night Split-Titration Protocol With BPAP-ST and AVAPS in Patients With Neuromuscular Disease
Patel, Salma , Gay, Peter C. , Olson, Eric J. , Shamoun, Fadi , Herold, Daniel L. , McNamara, Sarah, Selim, Bernardo J., Patel, Salma I, Gay, Peter, Morgenthaler, Timothy I. , Shamoun, Fadi E., Herold, Daniel, Selim, Bernardo, Kashyap, Rahul , McNamara, Sarah

Mayo Clinic

Journal of Clinical Sleep Medicine | December 14, 2018 | Volume: 14 | Issue: 12 | Pages: 2031-2035

10.5664/jcsm.7530 | PMID 30518448 Get It

New Onset vs Resolution of Central-Peripheral Rivalry–Type Diplopia in Patients Undergoing Epiretinal Membrane Peeling
Leske, David A. , Iezzi, Raymond , Holmes, Jonathan M. , Hatt, Sarah R. , Holmes, Jonathan M.

Mayo Clinic

JAMA Ophthalmology | December 13, 2018 | Volume: 137 | Issue: 3 | Pages: 293

10.1001/jamaophthalmol.2018.6042 | PMID 30543335 Get It

Seasonal variability is not observed in the rates of high anti‐A and anti‐B titers in plasma, apheresis platelet, and whole blood units tested by different methods
Harm, Sarah K., Yazer, Mark H. , Jacob, Eapen K., Mair, David , Raval, Jay S. , Shaz, Beth H. , Ziman, Alyssa , Collaborative, on behalf of the Biomedical Excellence for Safer Transfusion (BEST), Dunbar, Nancy M , Shaz, Beth H , Ziman, Alyssa , Raval, Jay S , Bub, Carolina Bonet , Cohn, Claudia S. , Kutner, José Mauro , Dunbar, Nancy M. , Collaborative, on behalf of the Biomedical Excellence for Safer Transfusion (BEST)

Mayo Clinic

Transfusion | December 12, 2018 | Volume: 59 | Issue: 2 | Pages: 762-767

10.1111/trf.15083 | PMID 30548267 Get It

BACKGROUNDABO‐incompatible platelet transfusions are common, and transfusions with ABO‐incompatible plasma are increasing with the use of group A plasma and group O whole blood (WB) in emergencies. Many centers screen blood products for anti‐A and/or anti‐B titers to help prevent hemolysis from ABO‐incompatible transfusions, yet titer methods and definition of high titers are not standardized.STUDY DESIGN AND METHODSThis international multicenter study collected data on anti‐A and anti‐B titer practices for plasma, apheresis platelet (AP), and WB units from January 2015 through December 2017 to determine the prevalence of high‐titer units using local definitions.RESULTSA total of 87,701 plasma, AP and WB units were screened for high‐titer anti‐A and/or anti‐B. High‐titer detection rates for group A plasma ranged 0%–13.6%; group A AP 2.7%–9.3%; group O AP 2.3%–65.7%; and group O WB 6.4%–20.7%. At the one center that collected group B AP, the high‐titer rate was 10.9%. High‐titer rates varied from month to month, as well as between years for a given month. There was no clear pattern of when high‐titer units were donated.CONCLUSIONThe prevalence of high‐titer plasma, AP, and WB units varies by titer method and local definition of high titer. Even at the lowest titer threshold of 50, a significant proportion of units had a high‐titer antibody, although the clinical relevance of this finding needs further investigation.
Hyperoxia-Induced Cellular Senescence in Fetal Airway Smooth Muscle Cells
Parikh, Pavan , Britt, Rodney D. , Manlove, L., Wicher, Sarah A. , Roesler, A.M., Ravix, Jovanka, Teske, Jacob J. , Kirkland, James L. , Tschumperlin, Daniel J. , Prakash, Y. S. , LeBrasseur, Nathan, Prakash, Y S , Teske, Jacob J , Thompson, Michael A. , Sieck, Gary C. , LeBrasseur, Nathan K. , Pabelick, Christina M.

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | December 3, 2018 | Volume: 61 | Issue: 1 | Pages: 51-60

10.1165/rcmb.2018-0176oc | PMID 30508396 Get It

Abstract Supplemental O2 (hyperoxia; 30–90% O2) is a necessary intervention for premature infants, but it contributes to development of neonatal and pediatric asthma, necessitating better understanding of contributory mechanisms in hyperoxia-induced changes to airway structure and function. In adults, environmental stressors promote formation of senescent cells that secrete factors (senescence-associated secretory phenotype), which can be inflammatory and have paracrine effects that enhance chronic lung diseases. Hyperoxia-induced changes in airway structure and function are mediated in part by effects on airway smooth muscle (ASM). In the present study, using human fetal ASM cells as a model of prematurity, we ascertained the effects of clinically relevant moderate hyperoxia (40% O2) on cellular senescence. Fetal ASM exposed to 40% O2 for 7 days exhibited elevated concentrations of senescence-associated markers, including β-galactosidase; cell cycle checkpoint proteins p16, p21, and p-p53; and the DNA damage marker p-γH2A.X (phosphorylated γ-histone family member X). The combination of dasatinib and quercetin, compounds known to eliminate senescent cells (senolytics), reduced the number of hyperoxia-exposed β-galactosidase–, p21-, p16-, and p-γH2A.X–positive ASM cells. The senescence-associated secretory phenotype profile of hyperoxia-exposed cells included both profibrotic and proinflammatory mediators. Naive ASM exposed to media from hyperoxia-exposed senescent cells exhibited increased collagen and fibronectin and higher contractility. Our data show that induction of cellular senescence by hyperoxia leads to secretion of inflammatory factors and has a functional effect on naive ASM. Cellular senescence in the airway may thus contribute to pediatric airway disease in the context of sequelae of preterm birth.
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis
Brown, Jennifer R. , Moslehi, Javid J. , Ewer, Michael S. , O’Brien, Susan , Ghia, Paolo , Cymbalista, Florence, Shanafelt, Tait D. , Fraser, Graeme , Rule, Simon , Dilhuydy, Marie‐Sarah, Cramer, Paula , Jaeger, Ulrich, Dreyling, Martin , Byrd, John C., Liu, Emily Y., Chang, Stephen, Bista, Amulya, Vempati, Rama, Boornazian, Lisa, Valentino, Rudolph, Reddy, Vijay , Mahler, Michelle, Yang, Huiying , Graef, Thorsten , Byrd, John C. , Treon, Steven , Burger, Jan A , Shanafelt, Tait D , Ghia, Paolo , Coutré, Steven , Dilhuydy, Marie‐Sarah, Byrd, John C. , Treon, Steven P. , Bista, Amulya R, Burger, Jan A. , Byrd, John C

Mayo Clinic

British Journal of Haematology | December 3, 2018 | Volume: 184 | Issue: 4 | Pages: 558-569

10.1111/bjh.15690 | PMID 30506764 Get It

SummaryIbrutinib, a Bruton tyrosine kinase inhibitor, is approved for treatment of various B‐cell malignancies. In ibrutinib clinical studies, low‐grade haemorrhage was common, whereas major haemorrhage (MH) was infrequent. We analysed the incidence of and risk factors for MH from 15 ibrutinib clinical studies (N = 1768), including 4 randomised controlled trials (RCTs). Rates of any‐grade bleeding were similar for single‐agent ibrutinib and ibrutinib combinations (39% and 40%). Low‐grade bleeding was more common in ibrutinib‐treated than comparator‐treated patients (35% and 15%), and early low‐grade bleeding was not associated with MH. The proportion of MH in RCTs was higher with ibrutinib than comparators (4.4% vs. 2.8%), but after adjusting for longer exposure with ibrutinib (median 13 months vs. 6 months), the incidence of MH was similar (3.2 vs. 3.1 per 1000 person‐months). MH led to treatment discontinuation in 1% of all ibrutinib‐treated patients. Use of anticoagulants and/or antiplatelets (AC/AP) during the study was common (~50% of patients) and had an increased exposure‐adjusted relative risk for MH in both the total ibrutinib‐treated population (1.9; 95% confidence interval, 1.2–3.0) and RCT comparator‐treated patients (2.4; 95% confidence interval, 1.0–5.6), indicating that ibrutinib may not alter the effect of AC/AP on the risk of MH in B‐cell malignancies.
Pediatric cancer care professionals’ experiences with an interprofessional communication intervention.
Das, Porag Jeet , Revette, Anna , Tulsky, James A. , Feraco, Angela M. , McCarthy, Sarah , Wolfe, Joanne

Mayo Clinic

Journal of Clinical Oncology | November 28, 2018 | Volume: 36 | Issue: 34_suppl | Pages: 53-53

10.1200/jco.2018.36.34_suppl.53 Get It

53 Background: The National Academy of Medicine recommends interprofessional collaboration to promote optimal patient- and family-centered care. We sought to understand whether medical and psychosocial professionals who participated in an interprofessional communication intervention perceived it as distinct from usual clinical care. Methods: Our intervention targeted “medical” (physicians, nurse practitioners) and “psychosocial” (social workers, psychologists) professionals. It consisted of an interprofessional family conference, using a structured conversation guide, conducted during the first 6 months of a child’s cancer care. Conferences aimed to enable families to share hopes and worries and ask questions about their child’s care. Clinicians received a 60-minute training focused on communication skills, such as eliciting families’ hopes and worries, and suggested approaches to collaborating during conferences. Clinicians participated in debriefing interviews after each conference (range 1-3). Three of us conducted thematic analysis of interview data. Results: Twenty-two professionals (6 attending MDs, 4 fellow MDs, 8 NPs, and 8 psychosocial clinicians) gave 34 interviews. Medical and psychosocial professionals described interprofessional family conferences as distinct from usual practice patterns, largely due to their interprofessional colleagues’ presence. This co-presence contributed to “being on the same page.” Conferences sometimes bred a new understanding of a family’s needs and consequent care changes. However, both medical and psychosocial professionals noted that psychosocial professionals often were not vocal contributors to the conference. Some psychosocial clinicians reported being unsure of “the rules.” Conclusions: An interprofessional communication intervention promoted shared understanding between interprofessional colleagues. However, medical professionals were described as more vocal, perhaps due to insufficient role clarity or medical dominance.
Detecting potential pleiotropy across cardiovascular and neurological diseases using univariate, bivariate, and multivariate methods on 43,870 individuals from the eMERGE network
Zhang, Xinyuan , Veturi, Yogasudha , Bone, William P. , Lucas, Anastasia, Hebbring, Scott J. , Stanaway, Ian B. , Jarvik, Gail P. , Crosslin, David R. , Larson, Eric B. , Sleiman, Patrick , Fasel, David , Wei, Wei‐Qi, Schaid, Daniel J. , Ritchie, Marylyn D. , Jarvik, Gail P , Wei, Wei-Qi , Verma, Shefali S. , Verma, Anurag , Denny, Joshua C. , Rasmussen‐Torvik, Laura J. , Pendergrass, Sarah A. , Smoller, Jordan W. , Håkonarson, Håkon , Weng, Chunhua , Kullo, Iftikhar J. , Chung, Wendy K.

Mayo Clinic

Biocomputing 2019 | November 28, 2018 | Volume: No volume available | Issue: No issue available | Pages: 272-283

10.1142/9789813279827_0025 Get It